Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Number of holders
-
146
-
Total 13F shares, excl. options
-
28,532,796
-
Shares change
-
+674,652
-
Total reported value, excl. options
-
$1,100,883,608
-
Value change
-
+$34,445,813
-
Put/Call ratio
-
51%
-
Number of buys
-
78
-
Number of sells
-
-58
-
Price
-
$38.58
Significant Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q4 2015
200 filings reported holding SRPT - Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2015.
Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) has 146 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28,532,796 shares
of 105,632,895 outstanding shares and own 27% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2,840,129 shares), Point72 Asset Management, L.P. (2,375,700 shares), FMR LLC (2,368,397 shares), PERCEPTIVE ADVISORS LLC (2,240,928 shares), BlackRock Fund Advisors (1,625,447 shares), STATE STREET CORP (1,601,718 shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1,164,690 shares), BlackRock Institutional Trust Company, N.A. (1,043,114 shares), MILLENNIUM MANAGEMENT LLC (958,495 shares), and JENNISON ASSOCIATES LLC (838,629 shares).
This table shows the top 146 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.